Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R. Goodlad, J. Nigthtingale, R. Playford.
Intestinal adaptation.
Intestinal failure, pp. 243-260
[2.]
N. Washizawa, L.H. Gu, L. Gu, K.P. Openo, D.P. Jones, T.R. Ziegler.
Comparative effects of glucagon-like peptide-2 (GLP-2),growth hormone (GH) and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
J Parent Ent Natu, 28 (2004), pp. 399-409
[3.]
J. Thulesen.
Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
Curr Protein Pept Sci, 5 (2004), pp. 51-65
[4.]
G.M. Keating, K. Wellington.
Somatropin (ZorbtiveTM) in short bowel syndorme.
Drugs, 64 (2004), pp. 1375-1381
[5.]
L.E. Matarese, L. Seidner, E. Steiger.
Growth hormone, glutamine,and modified diet for intestinal adaptation.
J Am Diet Assoc, 104 (2004), pp. 1265-1272
[6.]
Y. Zhou, X.T. Wu, G. Yang, W. Zhuang, M.L. Wei.
Clinical evidence of growth hormone, glutamine and a modified diet for short bowel syndrome: meta-analysis of clinical trials.
Asia Pac J Clin Nutr, 14 (2005), pp. 98-102
[7.]
D.G. Munroe, A.K. Gupta, F. Kooshesh, T.B. Rizkalla, H. Wang, L. Demchyshyn, et al.
Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Proc Nat Acad Sci, 96 (1999), pp. 1569-1573
[8.]
P.B. Jeppesen, B. Hartmann, J. Thulesen, J. Graff, J. Lohmann, B. Stenbaek, et al.
Glucagon-like peptide 2 improves nutrient absorbtion and nutritional status in Short-Bowel patients with no colon.
Gastoroenterology, 120 (2001), pp. 806-815
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición